Decreased level of novelty seeking in blood donors infected with toxoplasma

Neuroendocrinology Letters

Volumn 26, Issue 5, 2005, Pages 480-486

  Skallová, Anna ^a   Novotná, Martina ^a   Kolbeková, Petra ^a   Gašová, Zdenka ^b   Veselý, Vladimír ^c   Sechovská, Miluška ^c   Flegr, Jaroslav ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Behavior; Dopamine; Manipulation hypothesis; Parasite; Schizophrenia; TCI

Indexed keywords

PARASITE ANTIBODY;

AGE; ANTIBODY DETECTION; ARTICLE; BEHAVIOR DISORDER; BLOOD DONOR; BLOOD SAMPLING; CORRELATION ANALYSIS; CZECH REPUBLIC; DISEASE ASSOCIATION; DOPAMINE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS OF COVARIANCE; NONHUMAN; PERSONALITY TEST; PREVALENCE; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; RATING SCALE; RISK FACTOR; SCHIZOPHRENIA; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 29544436904     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Abramsky O, Litvin Y. Automimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia. Perspect Biol Med 1978; 22:104-14.
2. Alonso R, Chaudieu I, Diorio J, Krishnamurthy A, Quirion R, Boksa P. Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells. J Neurochem 1993; 61:1284-90.
3. Araujo DM, Lapchak PA, Collier B, Quirion R. Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res 1989; 498:257-66.
4. Arsenijevic D, Girardier L, Seydoux J, Chang HR, Dulloo AG. Altered energy balance and cytokine gene expression in a murine model of chronic infection with Toxoplasma gondii. Am J Physiol-Endoc M 1997; 35:908-17.
5. Cai GF, Radzanowski T, Villegas EN, Kastelein R, Hunter CA. Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J Immunol 2000; 165:2619-27.
6. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1988; 1:179-86.
7. Cloninger CR. The genetics and psychobiology of the seven-factor model of personality. In: Silk KR, editor. Biology of Personality Disorders. Washington DC: American Psychiatric Press, 1998. p. 63-92.
8. Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD. The temperament and character inventory (TCI): a guide to its development and use. St. Louis: Washington University Press, 1994.
9. Conley FK, Jenkins KA. Immunohistological study of the anatomic relationship of Toxoplasma antigens to the inflammatory response in the brains of mice chronically infected with Toxoplasma gondii. Infect Immun 1981; 31:1184-92.
10. De Sarro GB, Masuda Y, Ascioti C, Audino MG, Nistico G. Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone. Neuropharmacology 1990; 29:167-79.
11. Denicoff KD, Rubinow DR, Papa MZ, Simpson C, Seipp CA, Lotze MT, et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med 1987; 107:293-300.
12. Denkers EY, Gazzinelli RT. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 1998; 11:569-88.
13. Dunn AJ. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. Life Sci 1988; 43:429-35.
14. Fischer HG, Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol 2001; 166:2717-26.
15. Flegr J, Havlicek J, Kodym P, Maly M, Smahel Z. Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-controlstudy. BMC Infect Dis 2002; 2:art-11.
16. Flegr J, Hrdy I. Influence of chronic toxoplasmosis on some human personality factors. Folia Parasitol 1994; 41:122-6.
17. Flegr J, Kodym P, Tolarova V. Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biol Psychol 2000; 53:57-68.
18. Flegr J, Preiss M, Klose J, Havlicek J, Vitakova M, Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis? Biol Psychol 2003; 63:253-68.
19. Flegr J, Zitkova S, Kodym P, Frynta D. Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology 1996; 113:49-54.
20. Gerra G, Zaimovic A, Timpano M, Zambelli U, Begarani M, Marzocchi GF, et al. Neuroendocrine correlates of temperament traits in abstinent opiate addicts. J Subst Abuse 2000; 11:337-54.
21. Hansenne M, Pinto E, Pitchot W, Reggers J, Scantamburlo G, Moor M, et al. Further evidence on the relationship between dopamine and novelty seeking: a neuroendocrine study. Person Individ Diff 2002; 33:967-77.
22. Havlicek J, Gasova Z, Smith, AP, Zvara K, Flegr J. Decrease of psychomotor performance in subjects with latent 'asymptomatic' toxoplasmosis. Parasitology 2001; 122:515-20.
23. Kabiersch A, del Rey A, Honegger CG, Besedovsky HO. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav Immun 1988; 2:267-74.
24. Kodym P, Malý M, Svandová E, Lekatková H, Badoutová M, Vlková J, et al. Toxoplasma in the Czech Republic 1923-1999: first case to widespread outbreak. Int J Parasitol 2000; 30:11-8.
25. Kožený J, Tisanská L. Formální vlastnosti dotazníku TCI testované na datech adolescentuů. Českos Psychol 1998; 42:75-83.
26. Kramer W. Frontiers of neurological diagnosis in acquired toxoplasmosis. Psych Neurol Neuroch 1966; 69:43-64.
27. Ladee GA, Scholten JM, Meyes FEP. Diagnostic problems in psychiatry with regard to acquired toxoplasmosis. Psych Neurol Neuroch 1966; 69:65-82.
28. Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry 1993; 150:1408-10.
29. McAllister CG, van Kammen DP, Rehn TJ, Miller AL, Gurklis J, Kelley ME et al. Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am J Psychiatry 1995; 152:1291-7.
30. Minto A, Roberts FJ. The psychiatric complications of toxoplasmosis. Lancet 1959; 1180-2.
31. Novotná M, Hanusova J, Klose J, Preiss M, Havlicek J, Roubalová K, Flegr J. Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host. BMC Infect Dis 2005; 5: art 54.
32. O'Kusky JR, Boyes BE, Walker DG, McGeer EG. Cytomegalovirus infection of he developing brain alters catecholamine and indoleamine metabolism. Brain Res 1991; 559:322-30.
33. Petitto JM, McCarthy DB, Rinker CM, Huang Z, Getty T. Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J Neuroimmunol 1997; 73:183-90.
34. Pokorný J, Fruhbauer Z, Poledňáková S, Sýkora J, Zástěra M, Fialová D. Stanovení antitoxoplasmických protilatek IgG netodou ELISA (Assessment of antitoxoplasmatic IgG antibodies with the ELISA method). Cs Epidem 1989; 38:355-61.
35. Preiss M, Klose J. Diagnostika poruch osobnosti pomocí teorie C R Cloningera. (Diagnostics of personality disturbances using C R Cloninger theory). Psychiatrie 2003; 4:226-31.
36. Robertson JS. Toxoplasma skin- and dye-test surveys of severely subnormal patients in Lincolnshire. J Hyg Camb 1965; 63:89-98.
37. Ruegg RG, Gilmore J, Ekstrom RD, Corrigan M, Knight B, Tancer M, et al. Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects. Biol Psychiatry 1997; 42:1123-9.
38. Sawa A, Snyder SH. Schizophrenia: diverse approaches to a complex disease. Science. 2002; 296:692-5.
39. Schluter D, Kaefer N, Hof H, Wiestler OD, Deckertschluter M. Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am J Pathol 1997; 150:1021-35.
40. Stibbs HH. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol 1985; 79:153-7.
41. Torrey EF, Rawlings R, Yolken RH. The antecedents of psychoses: a case-control study of selected risk factors. Schizoph Res 2000; 46:17-23.
42. Torrey EF, Yolken RH. Could schizophrenia be a viral zoonosis transmitted from house cats. Schizophrenia Bull 1995; 21:167-71.
43. Torrey EF, Yolken RH. The schizophrenia-rheumatoid arthritis connection: Infectious, immune, or both? Brain Behav Immun 2002; 15:401-10.
44. Torrey EF, Yolken RH. Toxoplasma gondii and schizophrenia. Emerg Infect Dis 2003; 9:1375-80.
45. Warren J, Sabin AB. The complement fixation reaction in toxoplasmic infection. Proc Soc Exp Biol Med 1942; 51:11-6.
46. Webster JP. Rats, cats, people and parasites: the impact of latent toxoplasmosis on behaviour. Microb Infect 2001; 3:1037-45.
47. West WH, Tauer KW, Yannelli JR, Marshall GD, Orr DW, Thurman GB, et al. Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. New Engl J Med 1987; 316:898-905.
48. Wiesbeck GA, Mauerer C, Thome J, Jakob F, Boening J. Neuroendocrine support for a relationship between "novelty seeking" and dopaminergic function in alcohol-dependent men. Psychoneuroendocrinology 1995; 20:755-61.
49. Yolken RH, Bachmann S, Ruslanova I. Antibodies to Toxoplasma gondii in individuals with first- episode schizophrenia. Clin Infect Dis 2001; 32:1247.
50. Yolken RH, Torrey EF. Hypothesis of a viral etiology in bipolar disorder. In: Soares JC Gershon S, editors. Bipolar disorders. Basic mechanisms and therapeutic implications. New York: Marcel Dekker, Inc.; 2002. p. 305-15.
51. Zalcman S, Murray L, Dyck DG, Greenberg AH, Nance DM. Interleukin-2 and -6 induce behavioral-activating effects in mice. Brain Res 1998; 811:111-21.